NRx Pharmaceuticals, HOPE sign term sheet for $27M in funding
HOPE Therapeutics and a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP) announced signing of a Binding Term Sheet with Smith & Sauer, ...